[EN] 1-(4-PIPERIDINYL) BENZIMIDAZOLONES AS HISTAMINE H3 ANTAGONISTS<br/>[FR] 1-(4-PIPERIDINYL) BENZIMIDAZOLONES UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR H3 DE L'HISTAMINE
申请人:SCHERING CORP
公开号:WO2003103669A1
公开(公告)日:2003-12-18
Disclosed are histamine H3 antagonists of the formula (I) wherein
R1 is benzimidazolone derivative, M1 and M2 are
optionally substituted carbon or nitrogen, R2 includes optionally
substituted aryl or heteroaryl, and the remaining variables are as defined in
the specification. Also disclosed are pharmaceutical compositions comprising
the compounds of formula (I). Also disclosed are methods of treating various
diseases or conditions, such as, for example, allergy, allergy-induced airway
responses, and congestion (e.g., nasal congestion) using the compounds of Formula
(I). Also disclosed are methods of treating various diseases or conditions,
such as, for example, allergy, allergy-induced airway responses, and congestion
(e.g., nasal congestion) using the compounds of formula (I) in combination with
a H1 receptor antagonist.
揭示了公式(I)中的组胺H3拮抗剂,其中R1是苯并咪唑酮衍生物,M1和M2是可选择地取代的碳或氮,R2包括可选择地取代的芳基或杂环基,其余变量如规范中所定义。还揭示了包括公式(I)化合物的药物组合物。还揭示了使用公式(I)化合物治疗各种疾病或症状的方法,例如过敏、过敏引起的气道反应和充血(例如,鼻塞)的方法。还揭示了使用公式(I)化合物与H1受体拮抗剂结合治疗各种疾病或症状的方法,例如过敏、过敏引起的气道反应和充血(例如,鼻塞)。